Creative Planning - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Creative Planning ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$297,402
-29.0%
14,416
+1.5%
0.00%
-100.0%
Q2 2023$419,071
+75.8%
14,201
+37.2%
0.00%
Q1 2023$238,418
+14.8%
10,348
+38.5%
0.00%
Q4 2022$207,713
-7.3%
7,469
+2.5%
0.00%
Q3 2022$224,000
+7.7%
7,288
+3.0%
0.00%
Q2 2022$208,000
-4.6%
7,075
+4.4%
0.00%
Q1 2022$218,000
-6.0%
6,780
+30.2%
0.00%
Q4 2021$232,000
-11.8%
5,2080.0%0.00%
Q3 2021$263,000
-33.8%
5,208
-53.0%
0.00%
-100.0%
Q3 2020$397,00011,0800.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$219,569,00028.65%
ARCH Venture Management, LLC 5,168,749$152,116,00018.54%
Casdin Capital, LLC 1,500,000$44,145,0003.73%
Flagship Pioneering Inc. 2,619,968$77,106,0002.90%
Yiheng Capital Management, L.P. 1,014,684$29,862,0001.71%
SECTORAL ASSET MANAGEMENT INC 202,100$5,948,0001.20%
GILDER GAGNON HOWE & CO LLC 1,956,820$57,589,0001.03%
Artal Group S.A. 600,000$17,658,0000.94%
Temasek Holdings (Private) Ltd 5,369,487$158,024,0020.87%
BRANDYWINE MANAGERS, LLC 9,601$283,0000.69%
View complete list of DENALI THERAPEUTICS INC shareholders